Literature DB >> 12642502

Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice.

Xiaoling Xu1, Olga Aprelikova, Peter Moens, Chu-Xia Deng, Priscilla A Furth.   

Abstract

Breast tumor suppressor gene 1 (BRCA1) plays an essential role in maintaining genomic integrity. Here we show that mouse Brca1 is required for DNA-damage repair and crossing-over during spermatogenesis. Male Brca1(Delta11/Delta11)p53(+/-) mice that carried a homozygous deletion of Brca1 exon 11 and a p53 heterozygous mutation had significantly reduced testicular size and no spermatozoa in their seminiferous tubules. During spermatogenesis, homologous chromosomes from the mutant mice synapsed and advanced to the pachytene stage but failed to progress to the diplotene stage. Our analyses revealed that the Brca1 mutation affected cellular localization of several DNA damage-repair proteins. This included prolonged association of gammaH2AX with sites of DNA damage, reduced sex body formation, diminished Rad51 foci and absence of Mlh1 foci in the pachytene stage. Consequently, chromosomes from mutant mice did not form chiasmata, a point that connects exchanging homologous chromosomes. Brca1-mutant spermatocytes also exhibited decreased RNA expression levels of several genes that are involved in DNA-damage repair, including RuvB-like DNA helicase, XPB, p62 and TFIID. Of note, the premature termination of spermatogenesis at the pachytene stage was accompanied by increased apoptosis by both p53-dependent and p53-independent mechanisms. Thus, our study revealed an essential role of Brca1 in DNA-damage repair and crossing-over of homologous chromosomes during spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642502     DOI: 10.1242/dev.00410

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  63 in total

1.  Chromatin configuration and epigenetic landscape at the sex chromosome bivalent during equine spermatogenesis.

Authors:  Claudia Baumann; Christopher M Daly; Sue M McDonnell; Maria M Viveiros; Rabindranath De La Fuente
Journal:  Chromosoma       Date:  2011-01-28       Impact factor: 4.316

2.  Seeking new meiotic genes.

Authors:  Marco Barchi; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

Review 3.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

Review 4.  Male germ cell apoptosis: regulation and biology.

Authors:  Chandrima Shaha; Rakshamani Tripathi; Durga Prasad Mishra
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

5.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

6.  BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation.

Authors:  Brian P Chadwick; Timothy F Lane
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

Review 7.  Epigenetic processes implemented during spermatogenesis distinguish the paternal pronucleus in the embryo.

Authors:  Tammy F Wu; Diana S Chu
Journal:  Reprod Biomed Online       Date:  2008-01       Impact factor: 3.828

Review 8.  The consequences of asynapsis for mammalian meiosis.

Authors:  Paul S Burgoyne; Shantha K Mahadevaiah; James M A Turner
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

9.  miRNA and piRNA localization in the male mammalian meiotic nucleus.

Authors:  E Marcon; T Babak; G Chua; T Hughes; P B Moens
Journal:  Chromosome Res       Date:  2008-01-22       Impact factor: 5.239

10.  Arrested spermatogenesis and evidence for DNA damage in PTIP mutant testes.

Authors:  Kristopher R Schwab; Gary D Smith; Gregory R Dressler
Journal:  Dev Biol       Date:  2012-10-12       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.